Rotational Atherectomy Prior to Taxus Stent
1 other identifier
interventional
240
1 country
1
Brief Summary
The primary purpose of this study is to evaluate the long term effects of the polymer-based slow-release paclitaxel-eluting stent (TAXUS; Boston Scientific), with or without prior rotablation, in an angiographically well defined group of patients with complex calcified coronary lesions.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_4
Started Aug 2006
Longer than P75 for phase_4
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2006
CompletedFirst Submitted
Initial submission to the registry
September 25, 2006
CompletedFirst Posted
Study publicly available on registry
September 26, 2006
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2011
CompletedJuly 26, 2019
July 1, 2019
4.8 years
September 25, 2006
July 24, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
In-stent late lumen loss
9 months
Secondary Outcomes (6)
Major adverse cardiac events (MACE)
9 months
In-segment late lumen loss
9 months
In-segment binary restenosis
9 months
Primary angiographic success
Immediate
Procedural duration and contrast dye amount
Immediate
- +1 more secondary outcomes
Study Arms (2)
Rotational Atherectomy + PES
ACTIVE COMPARATORElective lesion preparation with rotational atherectomy priot to stent implantation
Standard Treatment (PES without Rotational Atherectomy)
ACTIVE COMPARATORStenting without prior rotational atherectomy, usually preceeded with balloon dilatation
Interventions
Eligibility Criteria
You may qualify if:
- Angiographically proven coronary artery disease
- Angina II-IV° following the Canadian Cardiovascular Society Classification criteria and/or reproducible ischemia in the target area by ECG or scintigraphy
- The patient signing an informed written consent
- First degree criteria
- De-novo lesion in a native coronary artery
- Target reference vessel diameter between 2.5 and 4.0 mm by visual estimation
- Luminal diameter reduction of 70-99% by visual estimation
- Moderate to severe calcification of the target lesion (clearly defined)
- Second degree criteria
- Ostial location
- Bifurcational lesions
- Long lesions (≥ 15mm)
You may not qualify if:
- Myocardial infarction within 4 weeks
- Left ventricular ejection fraction \< 30%
- Limited long term prognosis due to other conditions
- Unprotected left main lesions
- Coronary artery bypass graft stenoses
- In-stent restenoses
- Chronic total occlusions
- Target vessel thrombus
- Target vessel dissection
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Herz-Kreislauf-Zentrum Segeberger Kliniken GmbH
Bad Segeberg, 23795, Germany
Related Publications (8)
Stone GW, Ellis SG, Cox DA, Hermiller J, O'Shaughnessy C, Mann JT, Turco M, Caputo R, Bergin P, Greenberg J, Popma JJ, Russell ME; TAXUS-IV Investigators. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med. 2004 Jan 15;350(3):221-31. doi: 10.1056/NEJMoa032441.
PMID: 14724301BACKGROUNDStone GW, Ellis SG, Cox DA, Hermiller J, O'Shaughnessy C, Mann JT, Turco M, Caputo R, Bergin P, Greenberg J, Popma JJ, Russell ME; TAXUS-IV Investigators. One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent: the TAXUS-IV trial. Circulation. 2004 Apr 27;109(16):1942-7. doi: 10.1161/01.CIR.0000127110.49192.72. Epub 2004 Apr 12.
PMID: 15078803BACKGROUNDMorice MC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M, Colombo A, Schuler G, Barragan P, Guagliumi G, Molnar F, Falotico R; RAVEL Study Group. Randomized Study with the Sirolimus-Coated Bx Velocity Balloon-Expandable Stent in the Treatment of Patients with de Novo Native Coronary Artery Lesions. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med. 2002 Jun 6;346(23):1773-80. doi: 10.1056/NEJMoa012843.
PMID: 12050336BACKGROUNDMoses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O'Shaughnessy C, Caputo RP, Kereiakes DJ, Williams DO, Teirstein PS, Jaeger JL, Kuntz RE; SIRIUS Investigators. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med. 2003 Oct 2;349(14):1315-23. doi: 10.1056/NEJMoa035071.
PMID: 14523139BACKGROUNDSchofer J, Schluter M, Gershlick AH, Wijns W, Garcia E, Schampaert E, Breithardt G; E-SIRIUS Investigators. Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS). Lancet. 2003 Oct 4;362(9390):1093-9. doi: 10.1016/S0140-6736(03)14462-5.
PMID: 14550694BACKGROUNDWarth DC, Leon MB, O'Neill W, Zacca N, Polissar NL, Buchbinder M. Rotational atherectomy multicenter registry: acute results, complications and 6-month angiographic follow-up in 709 patients. J Am Coll Cardiol. 1994 Sep;24(3):641-8. doi: 10.1016/0735-1097(94)90009-4.
PMID: 8077533BACKGROUNDMoussa I, Di Mario C, Moses J, Reimers B, Di Francesco L, Martini G, Tobis J, Colombo A. Coronary stenting after rotational atherectomy in calcified and complex lesions. Angiographic and clinical follow-up results. Circulation. 1997 Jul 1;96(1):128-36. doi: 10.1161/01.cir.96.1.128.
PMID: 9236427BACKGROUNDAbdel-Wahab M, Richardt G, Joachim Buttner H, Toelg R, Geist V, Meinertz T, Schofer J, King L, Neumann FJ, Khattab AA. High-speed rotational atherectomy before paclitaxel-eluting stent implantation in complex calcified coronary lesions: the randomized ROTAXUS (Rotational Atherectomy Prior to Taxus Stent Treatment for Complex Native Coronary Artery Disease) trial. JACC Cardiovasc Interv. 2013 Jan;6(1):10-9. doi: 10.1016/j.jcin.2012.07.017. Epub 2012 Dec 19.
PMID: 23266232DERIVED
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Gert Richardt, MD
Herz-Kreislauf-Zentrum Segeberger Kliniken GmbH
- PRINCIPAL INVESTIGATOR
Ahmed A. Khattab, MD
Herz-Kreislauf-Zentrum Segeberger Kliniken GmbH
- PRINCIPAL INVESTIGATOR
Mohamed Abdel-Wahab, MD
Herz-Kreislauf-Zentrum Segeberger Kliniken GmbH
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 25, 2006
First Posted
September 26, 2006
Study Start
August 1, 2006
Primary Completion
May 1, 2011
Study Completion
May 1, 2011
Last Updated
July 26, 2019
Record last verified: 2019-07